- “The two doses, they’re not enough for omicron,” Pfizer CEO Albert Bourla said.
- Bourla said the two-dose vaccine does not provide robust protection against infection and its ability to prevent hospitalization has also declined.
- He said third shots are providing good protection against death, and “decent” protection against hospitalization.
Front Line Moral 